October 8th, 2026 | 5:00 - 5:45 PM (ET)

Echocardiography 201

Description:

This webinar builds on foundational amyloidosis imaging skills through a case-based exploration of advanced strain echocardiography, artificial intelligence, and the evolving role of ultrasound in clinical trials. As the therapeutic landscape for cardiac amyloidosis continues to expand, so does the sophistication required of diagnostic imaging. Clinical trials increasingly depend on precise, reproducible echo measures to track treatment response, and AI tools are rapidly moving from research curiosity to practical adjunct.

Using real-world cases, we will:

• Dig into nuanced strain patterns, including borderline and discordant apical sparing presentations
• Examine how AI-assisted analysis is beginning to support pattern recognition, quantification, and workflow efficiency in amyloidosis imaging
• Explore how echocardiographic endpoints are being used in ongoing and emerging clinical trials for both ATTR and AL amyloidosis, and what that means for imagers working with trial-enrolled patients.
  

Faculty:

• Sarah Cuddy, MD (Chair)
• Akhil Narang MD, FASE
• Jeremy Slivnick MD, FACC, FASE
• Megan Kraushaar BS, RCS, FASE

CME Information: 1 AMA PRA Category 1 Credit^TM   

CME Expiration: CME credit must be claimed by  10/8/27.

This activity is supported by an unrestricted educational grant from BridgeBio.

Learning Objectives:

• Analyze complex and borderline strain imaging cases, including discordant or atypical apical sparing patterns, to refine diagnostic and prognostic assessment in cardiac amyloidosis.
• Evaluate the role of AI-assisted analysis in strain echocardiography, distinguishing where it adds diagnostic value from where clinical judgment should take precedence.
• Describe how echocardiographic parameters are being used as endpoints in ongoing and emerging clinical trials for ATTR and AL cardiac amyloidosis.
• Apply case-based reasoning to identify diagnostic pitfalls in advanced amyloidosis imaging scenarios and formulate strategies to avoid misdiagnosis in complex presentations.
  

Accreditation Statement & CME Information

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosures:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

• TBA

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• TBA

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

• Contact:
  ASE Learning Hub